✦ LIBER ✦

Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis: results from an Australian expanded access program

✍ Scribed by Peter Foley; Michael Freeman; Kurt Gebauer; Dedee Murrell; Stephen Shumack; Christopher Tyson; George Varigos

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term continuous efalizumab therapy

✍ Alice B. Gottlieb; Tiffani Hamilton; Ivor Caro; Paul Kwon; Peter G. Compton; Cra 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 298 KB

Long-term efficacy of up to 15 months’ e

✍ Darryl P. Toth; Kim Papp; David Gratton 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

Safety and tolerability of efalizumab th

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Long-term efficacy and safety of adalimu

✍ Kenneth Gordon; Kim Papp; Yves Poulin; Yihua Gu; Stephen Rozzo; Eric H. Sasso 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 347 KB